This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Other. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Hanayuki Ohkura: Innovator in Adipose Tissue Research
Introduction
Hanayuki Ohkura is a notable inventor based in Suita, Japan. He has made significant contributions to the field of regenerative medicine, particularly through his research on multipotent progenitor cells derived from adipose tissue. His innovative work has the potential to advance therapeutic applications in various medical fields.
Latest Patents
Hanayuki Ohkura holds 1 patent for his invention titled "Multipotent progenitor cell derived from adipose tissue." This patent discloses a cell mass containing an adipose-tissue-derived multipotent progenitor cell. The method for producing this cell involves several steps, including the removal of erythrocytes from an adipose-tissue-derived cell mass and the subsequent purification of the desired multipotent progenitor cell.
Career Highlights
Throughout his career, Hanayuki Ohkura has focused on the development of techniques that enhance the extraction and application of multipotent progenitor cells. His work is pivotal in understanding how these cells can be utilized for regenerative therapies, potentially leading to breakthroughs in treating various conditions.
Collaborations
Hanayuki Ohkura has collaborated with esteemed colleagues such as Hiroshi Komoda and Yoshiki Sawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of regenerative medicine.
Conclusion
Hanayuki Ohkura's contributions to the field of adipose tissue research exemplify the importance of innovation in medical science. His work not only advances our understanding of multipotent progenitor cells but also opens new avenues for therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile